2026-01-15 - Analysis Report
```markdown
**Accenture PLC (ACN) Report**
=====================================

**Company Overview**
-------------------
Accenture PLC is a global professional services company.

**Return Rate Comparison**
-------------------------

| Stock | Cumulative Return |
| --- | --- |
| VOO (S&P 500) | 92.89% |
| ACN (Review) | 5.15% |
| **Divergence** | -87.74% |

The company's performance has diverged significantly from the S&P 500, with a cumulative return of -87.74% less than the comparison stock.

**Alpha, Beta Analysis**
-----------------------

| Period | CAGR | MDD | Alpha | Beta | Cap(B) |
| --- | --- | --- | --- | --- | --- |
| 2016-2018 | 2.0% | 20.5% | -2.0% | 1.1 | 87.5B |
| 2017-2019 | 44.0% | 20.5% | 26.0% | 1.1 | 130.6B |
| 2018-2020 | 2.0% | 30.3% | -19.0% | 1.0 | 162.0B |
| 2019-2021 | 73.0% | 30.3% | 30.0% | 1.0 | 257.1B |
| 2020-2022 | -15.0% | 32.0% | -13.0% | 1.1 | 165.5B |
| 2021-2023 | 14.0% | 32.0% | 13.0% | 1.2 | 217.6B |
| 2022-2024 | -34.0% | 25.5% | -53.0% | 1.1 | 218.2B |
| 2023-2025 | -29.0% | 36.2% | -91.0% | 0.9 | 166.4B |

**Recent Stock Price Fluctuations**
---------------------------------

| Figure | Value |
| --- | --- |
| 5-day SMA | $281.76 |
| 20-day SMA | $273.14 |
| 60-day SMA | $259.40 |
| Close | $288.54 |
| Last-Market | $288.54 ($276.80) |
| **Fluctuation** | Sharp rebound |

**Financial Indicators**
-----------------------

| Indicator | Value |
| --- | --- |
| RSI | 65.68 |
| PPO | 0.32 |
| MRI | 0.70 (High Investment Recommended) |
| **Risk Level** | Medium |
| **Recent Relative Divergence Change** | -0.20 (-) |
| **7-Day Rank Change** | 0 (0) |
| **7-Day Dynamic Expected Return Change** | 0.00 (0) |
| **Expected Return** | -236.20% |

**Recent News & Significant Events**
---------------------------------------

[2026-01-14] Accenture PLC (ACN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
[2026-01-14] Accenture (ACN) Valuation Check After Mixed Short And Long Term Share Price Returns - simplywall.st
[2026-01-14] Wells Fargo Raises Accenture (ACN) Price Target to $275 | ACN St - GuruFocus
[2026-01-14] Obermeyer Wealth Partners Reduces Position in Accenture PLC $ACN - MarketBeat
[2025-12-29] Buy Or Sell Accenture Stock? - Forbes
[2025-12-24] Here's Why Accenture (ACN) is a Strong Growth Stock - Nasdaq

**Analyst Opinions**
-------------------

Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 2.07 (~Buy)
- Opinions: 26
- Target Price (avg/high/low): 290.59 / 330.00 / 210.00

**Recent Earnings Analysis**
---------------------------

| Date | EPS | Revenue |
| --- | --- | --- |
| 2025-12-18 | 3.57 | 18.74 B$ |
| 2025-10-10 | 2.27 | 17.60 B$ |
| 2025-06-20 | 3.52 | 17.73 B$ |
| 2025-10-10 | 3.52 | 17.73 B$ |
| 2025-03-20 | 2.85 | 16.66 B$ |

**Revenue and Profitability**
---------------------------

| Quarter | Revenue | Profit Margin |
| --- | --- | --- |
| 2025-11-30 | $18.74B | 33.07% |
| 2025-08-31 | $17.60B | 31.89% |
| 2025-05-31 | $17.73B | 32.87% |
| 2025-02-28 | $16.66B | 29.86% |
| 2024-11-30 | $17.69B | 32.92% |

**Capital and Profitability**
---------------------------

| Quarter | Equity | ROE |
| --- | --- | --- |
| 2025-11-30 | $30.87B | 7.16% |
| 2025-08-31 | $31.20B | 4.53% |
| 2025-05-31 | $30.55B | 7.19% |
| 2025-02-28 | $29.25B | 6.11% |
| 2024-11-30 | $29.19B | 7.81% |

**Comprehensive Analysis**
-------------------------

Accenture PLC (ACN) has underperformed the S&P 500 significantly with a cumulative return of -87.74% less than the comparison stock. The company's CAGR has been volatile, ranging from 1.0% to 44.0% over different periods. The RSI is at 65.68, and the PPO is at 0.32, indicating a mixed technical outlook. The market risk indicator is at 0.70, indicating a medium risk level. The expected return is -236.20%, and the recent relative divergence change is -0.20 (-). The analyst consensus is buy with a mean of 2.07 (~Buy), indicating a neutral opinion from analysts. Overall, the stock's recent performance and financial indicators suggest a cautious approach.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.